Hypertension is the most common modifiable risk factor for cardiovascular disease and death, and lowering blood pressure with antihypertensive drugs reduces target organ damage and prevents cardiovascular disease outcomes.

Most hypertensive patients will need a combination of antihypertensive agents to achieve the therapeutic goals. Recent guidelines recommend initiating treatment with two drugs in those patients with a systolic blood pressure >20 mmHg and/or a diastolic blood pressure >10 mmHg above the goals, and in those patients with high cardiovascular risk. In addition, approximately 25% of patients will require three antihypertensive agents to achieve the therapeutic targets.


Foreword - European Cardiology Review – New Beginnings


European Cardiology Review 2014;9(1):6

Antiplatelet and Lipid-lowering Drugs in Hypertension


European Cardiology Review 2014;9(1):16–20

New Developments in Pulmonary Arterial Hypertension


European Cardiovascular Disease 2006;2(1):1–6

Landscape of Combination Therapy - Which Way Forward? Proceedings of the Satellite Symposium Held at the ESH European Meeting on Hypertension and Cardiovascular Protection, 27 April 2012, London


European Cardiology 2012;8(3):192–7